Tilray Shares Surge on Product Launch and Regulatory Speculation

Tilray Brands, Inc. saw its share price skyrocket in pre-market trading Friday, recording gains between 27% and 30%. The stock, which had closed the previous session at $8.43, climbed to an intraday high of $11.09. This significant rally is being driven by a dual catalyst: the strategic launch of a new premium cannabis product in Canada and emerging reports suggesting the Trump administration may be considering a reclassification of marijuana under U.S. federal law.

Market sentiment received a substantial boost from political developments. Credible sources indicate that U.S. President Donald Trump may direct federal agencies to downgrade marijuana from a Schedule I to a Schedule III controlled substance. Such a move Read more...